Stock Buybacks (Quarterly) Chart

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2016. Start Trial.
Date Value
September 30, 2026 -265.00M
June 30, 2026 0.00
March 31, 2026 0.00
December 31, 2025 0.00
September 30, 2025 0.00
June 30, 2025 0.00
March 31, 2025 0.00
December 31, 2024 0.00
September 30, 2024 0.00
June 30, 2024 0.00
March 31, 2024 0.00
December 31, 2023 -82.66M
September 30, 2023 0.047M
June 30, 2023 0.005M
March 31, 2023 0.217M
December 31, 2022 -0.208M
September 30, 2022 0.026M
June 30, 2022 0.061M
March 31, 2022 -1.532M
December 31, 2021 0.038M
September 30, 2021 -2.873M
Date Value
June 30, 2021 0.129M
March 31, 2021 -73.50M
December 31, 2020 -7.98M
September 30, 2020 -0.082M
June 30, 2020 -53.61M
March 31, 2020 -0.14M
December 31, 2019 -0.289M
September 30, 2019 -13.74M
June 30, 2019 -0.002M
March 31, 2019 -0.016M
December 31, 2018 -0.002M
September 30, 2018 -0.488M
June 30, 2018 -0.034M
March 31, 2018 -125.39M
December 31, 2017 0.003M
September 30, 2017 -50.36M
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -57.26M
Cue Biopharma, Inc. -50.63M
Faeth Therapeutics, Inc. -0.104M
Indaptus Therapeutics, Inc. 0.327M
Pyxis Oncology, Inc. -38.62M